Le Lann, Lucas
Jouve, Pierre-Emmanuel
Alarcón-Riquelme, Marta http://orcid.org/0000-0002-7632-4154
Jamin, Christophe http://orcid.org/0000-0002-9494-3223
Pers, Jacques-Olivier
Alvarez, Montserrat
Alvarez-Errico, Damiana
Azevedo, Nancy
Barbarroja, Nuria
Buttgereit, Anne
Cheng, Qingyu
Chizzolini, Carlo
Cremer, Jonathan
De Groof, Aurélie
De Langhe, Ellen
Ducreux, Julie
Dufour, Aleksandra
Gerl, Velia
Hernandez-Fuentes, Maria
Khodadadi, Laleh
Kniesch, Katja
Li, Tianlu
Lopez-Pedrera, Chary
Makowska, Zuzanna
Marañón, Concepción
Muchmore, Brian
Neves, Esmeralda
Rouvière, Bénédicte
Simon, Quentin
Trombetta, Elena
Varela, Nieves
Witte, Torsten
Aguilar-Quesada, Rocío
Aguirre-Zamorano, Maria Angeles
Almeida, Isabel
Baerlecken, Niklas
Balog, Attila
Belz, Doreen
Beretta, Lorenzo
Alonso, Ricardo Blanco
Bocskai, Márta
Brandão, Mariana
Rubio, José Luis Callejas
Campar, Ana
Castro-Villegas, Maria-Carmen
Cervera, Ricardo
Collantes, Eduardo
Cornec, Divi
Martínez, Alfonso Corrales
Deák, Magdolna
Devauchelle-Pensec, Valérie
Dulic, Sonja
Escudero-Contreras, Alejandro
Espinosa, Gerard
Faria, Raquel
Farinha, Fátima
Roldán, María Concepción Fernández
Anjos, Tania Gomes
González-Gay, Miguel A.
Hiepe, Falk
Hunzelmann, Nicolas
Jousse-Joulin, Sandrine
Kádár, Gabriella
Kovács, Laszló
Lauwerys, Bernard
Lehner, Michaela
López-Berrio, Antonio
Lories, Rik
Marinho, António
Marovac, Jacqueline
Meroni, Pier Luigi
Miranda, Blanca
Moleón, Immaculada Jiménez
Navarro-Linares, Héctor
Ortega-Castro, Rafaela
Ortego, Norberto
Garrido, Enrique Ramón
Raya, Enrique
Fernández, Raquel Ríos
Rodríguez-Pintó, Ignasi
Saraux, Alain
Stummvoll, Georg
Vasconcelos, Carlos
Zauner, Michael
,
,
Funding for this research was provided by:
Innovative Medicines Initiative (115565)
Agence Nationale de la Recherche (ANR-11-LABX-0016-001)
Article History
Received: 5 September 2019
Accepted: 22 June 2020
First Online: 14 July 2020
Competing interests
: M. H.-F. and J. M. are employees of UCB. A. B. and Z. M. are employees of BAYER Pharma. All other authors declare no competing financial and/or non-financial interests in relation to the work described.